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Morphological, Biochemical, and Molecular
Biological Characterization of a Rat
Rhabdomyosarcoma Cell Line during
Differentiation Induction In Vitro
by Claus D. Gerharz,* Johannes Doehmer,t Horst Mayer,t
Franz Oesch,t and Helmut Gabbert*
BA-HAN-1C is a clonal rat rhabdomyosarcoma cell line consisting ofproliferating mononuclear tumor
cells, some of which spontaneously fuse to form terminally differentiated postmitotic myotubelike giant
cells. Exposure to retinoic acid resulted in an inhibition ofproliferation and a marked increase in cellular
differentiation. The number of myotubelike giant cells significantly increased, and about 30%o of the
mononuclear tumor cells exhibited morphological features ofrhabdomyogenic differentiation which were
not observed in the mononuclear cells ofuntreated cultures. Morphological differentiation was paralleled
by an increase in total creatine kinase activity as a biochemical marker ofdifferentiation. These effects
of retinoic acid were preceded by an increased expression of proto-oncogene rafand transient expression
of proto-oncogene fos. The maximum level of fos expression was observed at 15 min and of rafat 12 hr
after exposure to retinoic acid. No expression of the proto-oncogenes src, myb, myc, ros, mos, erbA, and
erbB was detected.
Introduction
Retinoic acid has been shown to be a very potent in-
ducer ofdifferentiation, suppressing proliferation and en-
hancing differentiation in various tumor cell lines (1). At-
tention has, however, been focused mainly on carcinomas,
melanomas, and leukemias, whereas sarcomas have re-
ceived less attention, partly because cell-type specific
markers of differentiation are not readily available in
many established sarcoma cell lines. We report here on
the effects of retinoic acid on the clonal rat rhabdomy-
osarcoma cell line BA-HAN-1C. This cell line closely im-
itates embryonic rhabdomyogenesis (2). It consists ofmy-
ogenically committed but morphologically undif-
ferentiated mononuclear stem cells. Some ofthese mono-
nuclear tumor cells spontaneously fuse to form multinu-
clear myotubelike giant cells with ultrastructural features
of rhabdomyogenic differentiation. These myotubelike
giant cells were shown to have irreversibly withdrawn
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from the mitotic cycle and to represent terminally differ-
entiated postmitotic tumor cells (3).
Materials and Methods
Cells and Culture. The clonal cell line BA-HAN-1C
was derived from a dimethylbenzanthracene-induced
rhabdomyosarcoma in the rat (2). The standard growth
medium was Dulbecco-Vogt's modified Eagle medium
(DMEM, Gibco Europe, FRG), supplemented with 10%
heat-inactivated fetal calf serum, penicillin, and strepto-
mycin. Cell counts were perfonned with the Neubauer
hemocytometer chamber. For differentiation induction,
the stock solution of 5 mM retinoic acid (Serva, FRG) in
95% ethanol was diluted in standard growth medium.
In Vitro Morphology. For transmission electron mi-
croscopy, thetumorcellswere seeded onglass coverslips.
After incubation for 5 days, the tumor cells were fixed in
situ and further processed as previously described (2).
Fusion Assay. On the bottom of culture flasks four
arbitrarily located fields were marked. The area marked
outbythesefourfieldswas1/32thegrowthareaoftheculture
flask. Thenumberofmyotubelikegiantcellsinthemarked
fields was counted by phase contrast microscopy at in-
tervals of 24 hr. At the end of the observation period of
72 hr, the total number oftumor cells was determined in
each culture flask.GERHARZ ET AL.
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FIGURE 1. (A) Growth behavior and creatine kinase activity ofBA-HAN-1C after exposure to 1 ,uM retinoic acid. The creatine kinase activity
is significantly different from the control 72 hr after exposure to retinoic acid (p < 0.05; Wilcoxon test for unpaired samples). The difference
between the growth curves is statistically significant (p < 0.001; analysis of variance with two independent factors). ck, Creatine kinase
activity; n,ontroi, cell number in standard growth medium; nRA, cell number in growth medium supplemented with retinoic acid. (B) Absolute
number of myotubelike giant cells of BA-HAN-1C. Each value represents the mean ± SD of five experiments.
Total Creatine Kinase Activity. Tumor cells were
disrupted by sonication, and the total creatine kinase ac-
tivity, which was used as a biochemical marker of differ-
entiation (4), was determined on an Olympus AU 5031
analyzer using the CK-test (NAC-activated) from Merck
(Darmstadt, FRG).
Northern BlotAnalysis. Total cellular RNA was iso-
lated by the guanidine isothiocyanate method (5) and ana-
lyzed as previously described (6). Insert DNA forprobing
c-onc genes was obtained from the following plasmids: p-
c-fos (Exon IV), insert: PvuII/SacI; p-c-myb, insert: Eco
RI; p-EH-hu-c-myc, insert: SstI; p-erbBlerbA; p-src, in-
sert: PvuII; p-ros, insert: EcoRI/PvuII; p-Ki-ras, insert:
EcoRI; p-raf, insert: XhoI/SstII; p-mos, insert: XbaI/
HindIII. All plasmids have been described previously (7).
Insert DNA of pHKI encoding the human retinoic acid
receptor (hRAR(x) was used as a probe for retinoic acid
receptor (8).
Southern BlotAnalysis. Genomic DNA was isolated
from BA-HAN-1C cells, skeletal muscle, and liver. Chro-
mosomal DNA was digested with EcoRI to completion,
and 10 pug digested DNA in each lane was separated elec-
trophoretically on 0.7% agarose gel, denatured in 0.5M
NaOH/1 M NaCl, neutralized, transferred to nitrocellu-
lose, and hybridized -to the raf-specific probe. Hybridiza-
tion conditions were the same as previously described (6).
Cycloheximide Inhibition Studies. Cycloheximide
(5 ,ug/mL final concentration) was added to growth me-
dium which was exchanged after 4 hr in order to avoid
cytotoxic effects. Two kinds ofstudies were perforned.
Cycloheximide was either given at the same time as
retinoic acid or 4 hr before retinoic acid.
Results
Morphological and Biochemical Aspects of
Differentiation Induction
Exposure to 1 FLM retinoic acid resulted in a statis-
tically significant (p < 0.001) inhibition of proliferation
(Fig. 1A). The tumor cells were aligned in a more or-
derly arrangement 72 hrafter exposure to 1 ,uM retinoic
acid (Fig. 2B) and piling up was significantly reduced
as compared to the criss-cross growth pattern under
standard growth conditions (Fig. 2A). Transmission
electron microscopy revealed that about 30% of the
mononuclear tumor cells (Fig. 2D) exhibited irregular
bundles of thick myofilaments (12-15 nm in diameter)
and thin myofilaments (6-8 nm in diameter), which had
never been observed in the mononuclear tumor cells
under standard growth conditions (Fig. 2C). Further-
more, exposure to retinoic acid resulted in a dose- and
time-dependent increase inthe absolute numberofmyo-
tubelike giant cells (Fig. 1B). The ratio between the
numberofmyotubelikegiantcells(in '/32thegrowth area
ofthe culture flask) and the total number oftumor cells
per culture flask was calculated. For this ratio, a sta-
tistically significant (p < 0.001), dose-dependent in-
crease became evident from 4 x 10-6 + 0.0 (control)
to 30 x 10-6 13 x 106 (0.1 ,uM retinoic acid) and
310 x 10-6 ± 33 x 10-6 (1 ,uM retinoic acid) after 72
hr. Morphological differentiation induction was paral-
leled by a statistically significant increase (p < 0.05) in
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FIGURE 2. Morphology ofBA-HAN-1C tumor cells. (A) Criss-cross growth pattern ofmononuclear tumor cells in standard growth medium.
Bar = 100 ,um. (B) Moreregular arrangement ofspindle-shaped tumorcells oftenexhibitingmultiple nuclei (inset) afterexposure to retinoic
acid. Bar = 100 ,um. (C) Mononuclear tumor cell in standard growth medium without features ofrhabdomyogenic differentiation. Bar =
2 ,m. (D) Mononuclear tumor cell after exposure to retinoic acid with irregular bundles ofthick and thin myofflaments (arrows, inset). Bar
= 2 ,m; inset, bar = 0.5,m.
Molecular Biological Aspects of
Differentiation Induction
The initial screening for proto-oncogene expression in
BA-HAN-IC (Fig. 3A) revealed that the proto-oncogene
rafwas expressed at a low steady-state level under stan-
dard growth conditions. The expression ofrafmarkedly
increased after exposure to retinoic acid for 6 days (Fig.
3A). Furthennore, a low expression level of the proto-
oncogene ras was detected 6 days after exposure to re-
tinoic acid (Fig. 3A). No expression was detected for the
proto-oncogenesfos, src, myb, and ros (Fig. 3A), as well
as myc, mos, erbA, erbB (data not shown) before or 6
days after exposure to retinoic acid.
Kinetic studies onthe expression ofthe proto-oncogene
raf(Fig. 3D) showed a maximum expression level 12 hr
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FIGURE 3. (A) Northern blot analysis ofproto-oncogene expression in BA-HAN-1C tumor cells before (-) and after (+) exposure to 1 ,uM
retinoic acid for 6 days. Medium change with fresh retinoic acid was performed on day 5. (B,C) Proto-oncogene rafexpression ofBA-HAN-
1C tumor cells by Northern blot analysis after simultaneous exposure to retinoic acid and cycloheximide (B) or after preincubation with
cycloheximide for 4 hr followed by exposure to retinoic acid (C). (D,E) Kinetic studies on the expression of the proto-oncogenes raf(D)
andfos (E) by Northern blot analysis at indicated time intervals after exposure of BA-HAN-1C tumor cells to 1 p,M retinoic acid; note
second increase in rafexpression on day 6 after medium change with fresh retinoic acid. Each lane contained 15 p,g of total RNA.
afterexposure toretinoic acid, which declined belowbasal
levelwithinthenext60hr. Rafexpressionincreased again
following medium change with fresh retinoic acid. Kinetic
studies on the expression of the proto-oncogene fos
showed afastresponse toretinoic acidwithin 15min(Fig.
3E). The expression offos, however, rapidly declined to
undetectable levels within the next 45 min. Control ex-
periments showed that medium change without retinoic
acid was not sufficient to induce the proto-oncogenesfos
and raf(data not shown).
When cycloheximide, a potent inhibitor ofprotein syn-
thesis, was given at the same time as retinoic acid, the
increase in the expression ofthe proto-oncogene rafwas
not impaired (Fig. 3B). However, when cycloheximide
was added to the cells 4 hr before the addition ofretinoic
acid, no increase in proto-oncogene raf expression was
observed (Fig. 3C). The presence ofretinoic acid receptor
mRNAcouldbedemonstratedinBA-HAN-1Ctumorcells
before and after exposure to retinoic acid using a probe
obtained fromthe insert ofthe plasmid pHKI (8) encoding
the human retinoic acid receptor hRARa (data not
shown). Interestingly, retinoic acid receptormRNA could
not be detected in normal rat skeletal muscle. Studies on
the genomic arrangement of the proto-oncogene raf by
Southern blotting revealed no difference between hybrid-
izing DNA fragments in the chromosomal DNA of BA-
HAN-1C tumor cells, normal rat skeletal muscle, and rat
liver (data not shown).
Discussion
Numerous hypotheses on the molecular mode ofaction
of retinoic acid in the control of proliferation and differ-
entiation have been proposed (1). Recently, it has been
suggested that retinoic acid affects the expression of
proto-oncogenes involved in the control of proliferation
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and differentiation (9). This observation is confirmed by
our investigations that demonstrate that the effects of
retinoic acid onthe proliferation and differentiation ofBA-
HAN-1C tumor cells were preceded by remarkable
changes in the expression ofthe proto-oncogenesfos and
raf. The altered expression of the proto-oncogene rafis
ofparticular interest. The physiological function ofrafis
still obscure even though the biochemical function of its
gene product, a serine/threonine-specific kinase, has been
described (10).
Theinductionofc-rafin BA-HAN-1 cellsuponexposure
to retinoic acid during an early phase ofrhabdomyogenic
differentiation is reported for the first time. The direct
linkage between retinoic acid and rafexpression was con-
firmed by the cycloheximide experiments. When cycloh-
eximide, apotentinhibitor ofprotein synthesis, wasgiven
at the same time as retinoic acid, no change in the in-
creased expression of the proto-oncogene raf was ob-
served. This result indicated that the de novo synthesis
ofproteins, especiallyofthefosprotein, wasnotnecessary
to increase the expression of the proto-oncogene raf. In
contrast, when cycloheximide was given 4 hr before re-
tinoic acid, raf expression did not increase. This obser-
vation suggested the depletion ofa cellular protein, e.g.,
the retinoic acid receptor protein, which is supposedly
indispensable for the signal transduction of retinoic acid.
The existence of such a receptor protein in the cell line
BA-HAN-1C was also suggested by the presence of the
mRNA homologous to human retinoic receptor hRARa.
Induction ofthe proto-oncogenesfos and rafbyretinoic
acid preceded biochemical and morphological differentia-
tion in the rhabdomyosarcomacell line BA-HAN-1C. This
cell line may therefore serve as an appropriate experi-
mental system to further elucidate the regulatory events
taldng place during differentiation induction with retinoic
acid.
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